Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

29452 ARTÍCULOS , VIENDO DEL 28021 AL 28035

Amyloid-Related Imaging Abnormalities With Donanemab in Early Symptomatic Alzheimer Disease: Secondary Analysis of the TRAILBLAZER-ALZ and ALZ 2 Randomized Clinical Trials

Zimmer JA, Ardayfio P, Wang H, Khanna R, Evans CD, Lu M, Sparks J, Andersen S, Lauzon S, Nery ESM, Battioui C, Engle SE, Biffi A, Svaldi D, Salloway S, Greenberg SM, Sperling RA, Mintun M, Brooks DA, Sims JR.

JAMA Neurol. 2025 May 1;82(5):461-469. doi: 10.1001/jamaneurol.2025.0065.

evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer's disease

Cummings JL, Atri A, Feldman HH, Hansson O, Sano M, Knop FK, Johannsen P, León T, Scheltens P.

Alzheimers Res Ther. 2025 Jan 8;17(1):14. doi: 10.1186/s13195-024-01666-7.

Determination of Factors Associated With Urinary Incontinence in Older Individuals With Alzheimer's Disease: A Cross-Sectional Study

Özden F, Özkeskin M, Benzer Z, Uysal İ, Işık Eİ, Başer M.

Psychogeriatrics. 2025 Jul;25(4):e70058. doi: 10.1111/psyg.70058.

Technology readiness among UK-based cognitively unaffected older adults during the COVID-19 pandemic: potential implications for decentralised alzheimer's disease prevention trials

Taylor S, Dunn L, Udeh-Momoh C, Abbott K, Giannakopoulou P, Middleton L, Robinson O, Kalsi J, Kafetsouli D, Ford J.

BMC Geriatr. 2025 Jul 30;25(1):563. doi: 10.1186/s12877-025-06158-3.

[Observational study on the coincidence of Alzheimer's disease and idiopathic normal pressure hydrocephalus: analysis of coincidence, the influence on response to cerebrospinal fluid drainage and cerebrovascular copathology]

Beeke M, Sauer C, Petzold J, Schneider S, Frenzen K, Donix M, Reiß G, Brandt M, Haußmann R.

Nervenarzt. 2025 Dec;96(7):686-695. doi: 10.1007/s00115-025-01808-8. Epub 2025 Feb 27.

Disparities in COVID-19-Related Mortality Among Older Adults With Alzheimer's Disease and Related Dementias: Variations Over Time

Qin Q, Temkin-Greener H, Veazie P, Makineni R, Cai S.

J Appl Gerontol. 2025 Jan;44(1):11-17. doi: 10.1177/07334648241264908. Epub 2024 Jul 20.

Lucid episodes among people with Alzheimer's disease and related dementias and their impact on family caregiver stress and grief (LEAD): protocol for a longitudinal observational study

Griffin JM, Bangerter LR, Kim K, Liu Y, Batthyány A, Birkeland RW, Frangiosa TL, Nosheny RL, Gaugler J, Lapid MI.

BMJ Open. 2025 Jul 10;15(7):e098182. doi: 10.1136/bmjopen-2024-098182.

The Comparison of Oropharyngeal Dysphagia in Alzheimer's Disease versus Older Adults with Presbyphagia

Tanrıverdi M, Osmanoğlu E, Gelişin Ö, Çalım ÖF, Soysal P.

Dysphagia. 2025 Aug;40(4):792-800. doi: 10.1007/s00455-024-10777-0. Epub 2024 Oct 30.

Community-based participatory research on Alzheimer's disease and related dementias among Tibetan Buddhist monks in South India: The Lifestyle Assessment and Monastic Aging Study (LAMAS)

Namdul T, MacLehose R, Pasang T, Madesclaire O, Gyatso G, Henderson A, Buchwald D.

Alzheimers Dement. 2025 Nov;21(11):e70834. doi: 10.1002/alz.70834.

Differential MRI atrophy profiles and incident dementia: A cross-national comparison

Walters ME, Small BJ, Andel R, Lerch O, Horakova H, Molinari VA, Salemi JL, Vyhnalek M, Nedelska Z, Hort J; Alzheimer’s Disease Neuroimaging Initiative *.

J Alzheimers Dis. 2025 Oct;107(4):1539-1554. doi: 10.1177/13872877251371734. Epub 2025 Sep 3.

Addressing the knowledge and recruitment gap in Alzheimer's disease and precision medicine research among Native people: an innovative randomized controlled trial

Hebert LE, Kulbacki-Fabisiak C, Muller C, Boyd A, O'Leary M, Poole E, Ramos M, Barker D, Sinclair K, Manson SM, Buchwald D.

Ethn Health. 2025 May;30(4):471-490. doi: 10.1080/13557858.2025.2479456. Epub 2025 May 7.

Regional disparities of antidementia drug treatment in Germany: what can we learn for the new generation of Alzheimer's therapies

Platen M, Gläser E, Dahling V, Gesell D, Hauptmann M, Horenkamp-Sonntag D, Koller D, Kubat D, Marschall U, Riederer C, Scheibner H, Schroth J, Swart E, Michalowsky B.

Alzheimers Res Ther. 2025 Dec 4;17(1):259. doi: 10.1186/s13195-025-01902-8.

Alzheimer Disease Patients Who Survived COVID-19 Have Rapid Disease Progression and a Higher Risk of Death at 5-year Follow-up: A Retrospective Cohort Study

Ursi GZ, da Silva MR, Nakakogue LM, Fernandes KBP, Bignardi PR.

Alzheimer Dis Assoc Disord. 2025 Oct-Dec 01;39(4):277-282. doi: 10.1097/WAD.0000000000000700. Epub 2025 Nov 12.

Variation in Phenotype Definitions in Observational Clinical Research: A Review of Three Conditions

Shoaibi A, Ostropolets A, Weaver J, Rao GA, Golozar A, Swerdel J, Huser V, Adam A, Alshammari T, Anikpezie N, Baumgartner WA Jr, Brand M, Fan R, Kanter AS, Kern D, Melisa S, Minty E, Mo J, Oluwalade B, Schilling LM, Spence H, Stocking JC, Zhang L, Ryan P.

AMIA Annu Symp Proc. 2025 May 22;2024:1021-1029. eCollection 2024.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias